|
| Review | Studies (participants) | Intervention | Comparison | Main outcomes | Risk assessment tool | Adverse effect |
|
| Fan [26] | 14 (1320) | Acupuncture and moxibustion | Western medicine/Chinese medicine | Total effective rate, VAS, adverse effects | Jadad | Y |
| Lan et al. [27] | 7 (822) | Acupuncture and moxibustion/Acupuncture and moxibustion + others | Placebo acupuncture/Western medicine/blank | Total effective rate | RoB | N |
| Chen et al. [28] | 14 (1320) | Heat-sensitive moxibustion | No limit | Clinical effective rate | RoB | Y |
| Xu et al. [29] | 15 (1261) | Moxibustion/Moxibustion + others | Not moxibustion | Total effective rate | Jadad | N |
| Wang et al. [30] | 12 (957) | Heat sensitive moxibustion/Heat sensitive moxibustion + others | No limit | Total effective rate, symptom score of the dysmenorrhea | Jadad | N |
| Zhou et al. [31] | 7 (542) | Heat sensitive moxibustion | No limit | Clinical effective rate, cure rate, CMSS | RoB | N |
| Lu et al. [32] | 13 (1524) | Indirect moxibustion | Western medicine/Chinese medicine | Total effective rate, symptom of the dysmenorrhea, adverse effects | Jadad, RoB | Y |
| Woo et al. [33] | 60 (5901) | Acupuncture and moxibustion | Western medicine/sham acupuncture/blank | Pain intensity, pain relief、SF-36 | RoB | Y |
| Tong et al. [34] | 23 (2770) | Acupuncture and moxibustion | Sham acupuncture | VAS, VRS, NRS | RoB | N |
| Fan et al. [35] | 13 (1040) | Warm needling method | Western medicine/Chinese medicine | Total effective rate, symptom score of the dysmenorrhea | RoB | N |
| Sun et al. [36] | 8 (644) | Acupressure/acupressure + others | Acupuncture + others | Symptom score of the dysmenorrhea, total effective rate, VAS | Jadad | N |
| Qin et al. [37] | 19 (1760) | Acupuncture and moxibustion | Western medicine/Chinese medicine | Total effective rate | Jadad | N |
| Gou [38] | 10 (586) | Moxibustion | Not moxibustion | Total effective rate, symptom of the dysmenorrhea | RoB | Y |
| Liu et al. [39] | 14 (1123) | Acupuncture and moxibustion/acupuncture and moxibustion + Western medicine/acupuncture and moxibustion + Chinese medicine | Western medicine/Chinese medicine | Total effective rate | Jadad | N |
| Gou et al. [40] | 12 (786) | Moxibustion | Not moxibustion | Total effective rate pain | RoB | Y |
| Wang [12] | 12 (1236) | Indirect moxibustion | Western medicine/Chinese medicine | Total effective rate | RoB | N |
| Lin et al. [41] | 15 (1594) | Acupuncture and moxibustion | Western medicine/Chinese medicine | Clinical effective rate, symptom score of the dysmenorrhea | Jadad | N |
| Qin et al. [42] | 20 (2134) | Acupuncture and moxibustion | Western medicine/Chinese medicine | Total effective rate, symptom score of the dysmenorrhea | RoB | N |
| Listijo [43] | 11 (412) | Moxibustion | Western medicine/Chinese medicine/acupuncture | Total effective rate | Jadad, RoB | Y |
| Chen et al. [44] | 28 (2787) | Acupuncture and moxibustion/Acupuncture and Moxibustion + others | Western medicine/Chinese medicine | Total effective rate, symptom score of the dysmenorrhea | Jadad | Y |
| Yang [45] | 32 (3910) | Acupuncture and moxibustion | No treatment/placebo/acupressure/Western medicine/Chinese medicine | VAS | Jadad | Y |
| Chen et al. [46] | 8 (589) | Acupressure/Acupuncture and moxibustion | Acupuncture/sham acupuncture | VAS | RoB | N |
| Yu et al. [24] | 9 (3118) | Electroacupuncture | Pharmacological treatment/nonacupoints/waiting-list groups | VAS, RSS | RoB | N |
| Xu et al. [11] | 16 (1679) | Acupoint-stimulation | NSAIDs | Total effective rate, symptom score of the dysmenorrhea | RoB | N |
| Smith et al. [15] | 42 (4640) | Acupressure/Acupuncture and moxibustion | NSAIDs/placebo/blank | VAS | RoB | Y |
| Xu et al. [25] | 20 (2134) | Acupressure/moxibustion | Not acupuncture and moxibustion | Total effective rate, pain intensity | RoB | N |
| Chung et al. [47] | 25 (3109) | Acupoint stimulation | No limit | Total effective rate, adverse effects | Jadad | Y |
| Cho and Hwang [48] | 27 (2806) | Acupuncture | No limit | Pain relief | RoB | Y |
|
